振江股份(603507.SH):持股5%以上的鴻立投資開展融資融券業務 涉及500萬股
格隆匯 6 月 29日丨振江股份(603507.SH)公佈,公司於近日收到持股5%以上股東上海鴻立股權投資有限公司(“鴻立投資”)關於開展融資融券業務的通知,現將有關情況公告如下:
鴻立投資與渤海證券開展融資融券業務,將其持有的公司無限售流通股500萬股轉入渤海證券客户信用交易擔保證券賬户中,該部分股份所有權未發生轉移。
截至公告披露日,鴻立投資合計持有公司股份1300萬股,佔公司總股本的10.15%。其中:通過普通證券賬户持有800萬股,佔公司總股本的6.25%;通過渤海證券客户信用交易擔保證券賬户持有公司股份500萬股,佔公司總股本的3.90%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.